We are live on ! Find out more
GDRX icon

GoodRx Holdings

161 hedge funds and large institutions have $510M invested in GoodRx Holdings in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 43 increasing their positions, 60 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $3.14M | Put options by funds: $1.2M

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

1.18% less ownership

Funds ownership: 120.21%119.03% (-1.2%)

12% less funds holding

Funds holding: 182161 (-21)

15% less capital invested

Capital invested by funds: $600M → $510M (-$90.8M)

28% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 60

37% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 51

Holders
161
Holders Change
-21
Holders Change %
-11.54%
% of All Funds
2.11%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
32
Increased
43
Reduced
60
Closed
51
Calls
$3.14M
Puts
$1.2M
Net Calls
+$1.94M
Net Calls Change
-$680K
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
76
Wells Fargo
California
$189K +$28.8K +6,554 +17%
GS
77
Gagnon Securities
New York
$186K +$1.38K +313 +0.7%
State of Tennessee, Department of Treasury
78
State of Tennessee, Department of Treasury
Tennessee
$178K +$57.2K +13,009 +45%
KCPG
79
Kavar Capital Partners Group
Kansas
$174K
PA
80
PharVision Advisers
Florida
$172K +$179K +40,737 New
Fidelity Investments
81
Fidelity Investments
Massachusetts
$156K +$141K +32,032 +670%
VI
82
Versor Investments
New York
$155K +$161K +36,600 New
Commonwealth Equity Services
83
Commonwealth Equity Services
Massachusetts
$151K +$40.9K +9,300 +35%
Janus Henderson Group
84
Janus Henderson Group
United Kingdom
$137K
NW
85
NewEdge Wealth
Pennsylvania
$134K +$177K +40,370 New
EC
86
EntryPoint Capital
New York
$133K -$204K -46,382 -60%
Walleye Capital
87
Walleye Capital
New York
$116K -$25.4K -5,785 -17%
JF
88
Jump Financial
Illinois
$109K +$60.1K +13,662 +113%
PP
89
PDT Partners
New York
$109K -$1.4M -318,264 -93%
ASRS
90
Arizona State Retirement System
Arizona
$108K -$3.82K -870 -3%
SWM
91
Steinberganna Wealth Management
New York
$108K +$112K +25,500 New
LPL Financial
92
LPL Financial
California
$106K -$118K -26,918 -52%
Osaic Holdings
93
Osaic Holdings
Arizona
$102K -$462 -105 -0.4%
FFG
94
Fortem Financial Group
California
$93.1K +$8.79K +2,000 +10%
SS
95
SBI Securities
Japan
$84.9K -$6.42K -1,460 -7%
Royal Bank of Canada
96
Royal Bank of Canada
Ontario, Canada
$82K -$23.9K -5,445 -22%
DTL
97
Dynamic Technology Lab
Singapore
$79K +$82.1K +18,683 New
Cerity Partners
98
Cerity Partners
New York
$74.8K +$77.7K +17,674 New
Lazard Asset Management
99
Lazard Asset Management
New York
$72K -$563 -128 -0.7%
PAS
100
Point72 Asia (Singapore)
Singapore
$69.4K -$13.8K -3,132 -16%

GDRX Hedge Fund Activity: Q3 2025 in Review

161 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2025, worth a combined $510M — down 15% from $600M a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of GDRX and 32 opened new positions — a net loss of 19 holders — while 60 trimmed existing stakes and 43 added.

The largest buyer was LSV Asset Management, adding an estimated $8.67M. The largest seller was Lakewood Capital Management, cutting an estimated $11.7M.

  • 161 institutional investors held GoodRx Holdings (GDRX) as of Q3 2025, down from 182 in Q2 2025.
  • Funds reported $510M of GoodRx Holdings stock for Q3 2025, down 15% quarter-over-quarter.
  • 32 funds opened new GoodRx Holdings positions in Q3 2025 and 51 closed out, a net change of -19 holders.
  • The largest GoodRx Holdings buyer in Q3 2025 was LSV Asset Management, an estimated $8.67M added.
  • The largest GoodRx Holdings seller in Q3 2025 was Lakewood Capital Management, an estimated $11.7M sold.

Based on aggregated 13F filings for Q3 2025.